XML 38 R21.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Intangible Assets and Goodwill | 3 Months Ended
--- | ---
Dec. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets and Goodwill | Intangible Assets and Goodwill Intangible assets consisted of the following:
Description | As of December 30, 2017 |  | As of September 30, 2017
Gross Carrying Value |  | Accumulated Amortization |  | Gross Carrying Value |  | Accumulated Amortization
Acquired intangible assets: |  |  |  |  |  |  |
Developed technology | $ | 4,528.8 |  |  | $ | 2,266.7 |  |  | $ | 4,528.7 |  |  | $ | 2,186.8 |
In-process research and development | 46.0 |  |  | — |  |  | 46.0 |  |  | — |
Customer relationships | 556.7 |  |  | 402.8 |  |  | 552.8 |  |  | 393.8 |
Trade names | 310.3 |  |  | 161.1 |  |  | 310.3 |  |  | 156.4 |
Distribution agreement | 42.0 |  |  | 4.1 |  |  | 42.0 |  |  | 2.8 |
Non-competition agreements | 1.5 |  |  | 0.1 |  |  | 1.5 |  |  | 0.1 |
Business licenses | 2.5 |  |  | 2.2 |  |  | 2.4 |  |  | 2.2 |
Total acquired intangible assets | $ | 5,487.8 |  |  | $ | 2,837.0 |  |  | $ | 5,483.7 |  |  | $ | 2,742.1 |
Internal-use software | 65.8 |  |  | 48.2 |  |  | 64.5 |  |  | 46.1 |
Capitalized software embedded in products | 15.5 |  |  | 2.6 |  |  | 14.3 |  |  | 2.0 |
Total intangible assets | $ | 5,569.1 |  |  | $ | 2,887.8 |  |  | $ | 5,562.5 |  |  | $ | 2,790.2 |
The estimated remaining amortization expense of the Company's acquired intangible assets as of December 30, 2017 for each of the five succeeding fiscal years is as follows:
Remainder of Fiscal 2018 | $ | 283.1 |
Fiscal 2019 | $ | 366.0 |
Fiscal 2020 | $ | 354.8 |
Fiscal 2021 | $ | 333.2 |
Fiscal 2022 | $ | 320.3 |
The Company conducted its fiscal 2017 impairment test on the first day of the fourth quarter, and used a discounted cash flow method (DCF) to estimate the fair value of its reporting units as of July 2, 2017. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing Step 1, all of the Company's reporting units had fair values exceeding their carrying values, and as such, Step 2 of the impairment test was not required. However, one of its reporting units, Medical Aesthetics, had a fair value as of the measurement date that exceeded its carrying value by 2% with goodwill of $683.5 million. The Medical Aesthetics reporting unit is solely comprised of the Cynosure, Inc. business, which the Company acquired on March 22, 2017. In connection with the Company's annual strategic planning process and annual goodwill impairment test, it lowered its estimated financial projections for this business as a result of its then current operating performance being below expectations, which the Company primarily attributed to the significant turnover in the U.S. sales force in 2017 following the date of acquisition. The Company is continuing its efforts to rebuild the U.S. sales force and this continues to affect short term performance. The Company’s long-term outlook for the Medical Aesthetics business has not materially changed. The Company is continuing to monitor the operating performance of this reporting unit compared to the projections used in the annual impairment test, as well as current market and business conditions, to determine if an event has occurred or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. The Company has evaluated these factors and determined that no significant events occurred or circumstances changed during the period ended December 30, 2017 that would suggest it is more likely than not that the fair value of the reporting unit has declined below its carrying value. In the event the Company is unsuccessful in its efforts to rebuild the U.S. sales force or its efforts take significantly longer than expected, or other adverse conditions are identified, future operating performance may be below forecasted projections. If this occurs, the Company may need to revise its long-term growth rates or increase discount rates, and these factors could result in a decline in the fair value of the reporting unit and the Company may be required to record a goodwill impairment charge.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration